Evaluating the impact of AI on insurance: the four emerging AI- and data-driven business models
Emerald Open Research · 2023
DOI: 10.1108/eor-01-2023-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerald Open Research, 2023. Verfasst von Alex Zarifis und 2 weiteren Autor:innen. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
The increasing capabilities of artificial intelligence (AI) are changing the way organizations operate and interact with users both internally and externally. The insurance sector is currently using AI in several ways but its potential to disrupt insurance is not clear. This research evaluated the implementation of AI-led automation in 20 insurance companies. The findings indicate four business models (BM) emerging: In the first model the insurer takes a smaller part of the value chain allowing others with superior AI and data to take a larger part. In the second model the insurer keeps the same model and value chain but uses AI to improve effectiveness. In the third model the insurer adapts their model to fully utilize AI and seek new sources of data and customers. Lastly in the fourth model a technology focused company uses their existing AI prowess, superior data and extensive customer base, and adds insurance provision.
Zitieren
APA
Zarifis, A., Holland, C. P., & Milne, A. (2023). Evaluating the impact of AI on insurance: the four emerging AI- and data-driven business models. Emerald Open Research. https://doi.org/10.1108/eor-01-2023-0001
Vancouver
Zarifis A, Holland CP, Milne A. Evaluating the impact of AI on insurance: the four emerging AI- and data-driven business models. Emerald Open Research. 2023. doi:10.1108/eor-01-2023-0001
BibTeX
@article{Zarifis2023,
author = {Zarifis, Alex and Holland, Christopher P. and Milne, Alistair},
title = {Evaluating the impact of AI on insurance: the four emerging AI- and data-driven business models},
journal = {Emerald Open Research},
year = {2023},
doi = {10.1108/eor-01-2023-0001}
}
EUVIMED